Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP)

MLA

Jean-Marc Naccache, et al. “Study Protocol: Exploring the Efficacy of Cyclophosphamide Added to Corticosteroids for Treating Acute Exacerbation of Idiopathic Pulmonary Fibrosis; a Randomized Double-Blind, Placebo-Controlled, Multi-Center Phase III Trial (EXAFIP).” BMC Pulmonary Medicine, vol. 19, no. 1, Apr. 2019, pp. 1–8. EBSCOhost, https://doi.org/10.1186/s12890-019-0830-x.

APA

Jean-Marc Naccache, Melissa Montil, Jacques Cadranel, Marine Cachanado, Vincent Cottin, Bruno Crestani, Dominique Valeyre, Benoit Wallaert, Tabassome Simon, & Hilario Nunes. (2019). Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP). BMC Pulmonary Medicine, 19(1), 1–8. https://doi.org/10.1186/s12890-019-0830-x

Chicago

Jean-Marc Naccache, Melissa Montil, Jacques Cadranel, Marine Cachanado, Vincent Cottin, Bruno Crestani, Dominique Valeyre, Benoit Wallaert, Tabassome Simon, and Hilario Nunes. 2019. “Study Protocol: Exploring the Efficacy of Cyclophosphamide Added to Corticosteroids for Treating Acute Exacerbation of Idiopathic Pulmonary Fibrosis; a Randomized Double-Blind, Placebo-Controlled, Multi-Center Phase III Trial (EXAFIP).” BMC Pulmonary Medicine 19 (1): 1–8. doi:10.1186/s12890-019-0830-x.